Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study finds

Type 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study. Read More in FOX News.   Read More in Red Pill NOWlej.